• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: 3M ESPE DENTAL PRODUCTS 3M ESPE CLINPRO WHITE VARNISH; CAVITY VARNISH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

3M ESPE DENTAL PRODUCTS 3M ESPE CLINPRO WHITE VARNISH; CAVITY VARNISH Back to Search Results
Catalog Number 12247BL
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Liver Damage/Dysfunction (1954); Patient Problem/Medical Problem (2688)
Date of Event 12/27/2016
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
3m espe clinpro white varnish (also known as vanish 5% sodium fluoride white varnish) has been thoroughly evaluated for biocompatibility and found to be safe for its intended use.In addition, the global clinical complaint history for this product is favorable, with a low level of total complaints and no observable trends in the types of complaints received.There have been no other reported complaints similar to the current complaint.
 
Event or Problem Description
On (b)(6) 2017, it was reported to 3m that a (b)(6) female sought emergency medical care and was hospitalized.One week prior the patient received dental treatment involving 3m espe clinpro white varnish (also known as vanish 5% sodium fluoride white varnish), melon flavor and a non-3m product.The patient went home without incident following treatment.A few days later, the patient experienced dark urine, followed by yellow skin pigmentation, at which time emergency medical care was sought.Lab tests were conducted and patient was moved to intensive care.A liver biopsy was taken which resulted in a diagnosis of giant hepatitis cells with little presence of plasma cells.Following the diagnosis, the patient received steroids treatment which stabilized her situation.The patient is currently reported to be stabilized and continues with a treatment regimen of 10mg/day prednisone and 75mg/day immuran.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
3M ESPE CLINPRO WHITE VARNISH
Common Device Name
CAVITY VARNISH
Manufacturer (Section D)
3M ESPE DENTAL PRODUCTS
2510 conway avenue
st. paul MN 55144 1000
MDR Report Key6815320
Report Number3005174370-2017-00046
Device Sequence Number964087
Product Code LBH
Combination Product (Y/N)N
Initial Reporter CountryIS
PMA/510(K) Number
K092141
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,other
Initial Reporter Occupation Patient Family Member or Friend
Type of Report Initial
Report Date (Section B) 08/23/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Dental Hygienist
Device Catalogue Number12247BL
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/16/2017
Initial Report FDA Received Date08/23/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization;
Patient Age10 YR
-
-